[1] World Health Organization. Global tuberculosis report 2025. Geneva: World Health Organization. 2025. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2025. [2026-2-3].
[2] Sterling TR, Njie G, Zenner D, Cohn DL, Reves R, Ahmed A, et al. Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep 2020;69(1):1 − 11. https://doi.org/10.15585/mmwr.rr6901a1.
[3] Tayal A, Kabra SK. Tuberculosis preventive treatment. Indian J Pediatr 2024;91(8):823 − 9. https://doi.org/10.1007/s12098-023-04969-z.
[4] Zhao YL, Chen MT. Technical guidelines for tuberculosis prevention and treatment in China. Beijing: People’s Medical Publishing House. 2021. (In Chinese).
[5] National Disease Control and Prevention Administration, National Health Commission of the People’s Republic of China, National Development and Reform Commission, Ministry of Education of the People’s Republic of China, Ministry of Public Security of the People’s Republic of China, Ministry of Justice of the People’s Republic of China, et al. Circular on issuing the “national tuberculosis prevention and control plan (2024–2030)”. 2024. https://www.gov.cn/zhengce/zhengceku/202412/content_6991217.htm. [2025-10-15]. (In Chinese).
[6] Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, Torres M. Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol 2020;11:2006. https://doi.org/10.3389/fimmu.2020.02006.
[7] Godoy P. Guidelines on controlling latent tuberculosis infection to support tuberculosis elimination. Rev Esp Sanid Penit 2021;23(1):28 − 36. https://doi.org/10.18176/resp.00028.
[8] Hannah A, Dick M. Identifying gaps in the quality of latent tuberculosis infection care. J Clin Tuberc Other Mycobact Dis 2020;18:100142. https://doi.org/10.1016/j.jctube.2020.100142.
[9] Balasubramanian R, Shearer K, Mudzengi D, Hippner P, Golub JE, Chihota V, et al. Modeling the impact of universal tuberculosis molecular testing and timing of tuberculosis preventive treatment during antiretroviral therapy initiation in South Africa. AIDS 2023;37(15):2371 − 9. https://doi.org/10.1097/QAD.0000000000003707.
[10] Swain S, Kumar A, Vishwakarma VK, Aayilliath KA, Mittal A, Wig N. Diagnosis and management of latent tuberculosis infection: updates. Infect Disord Drug Targets 2024;24(4):12 − 9. https://doi.org/10.2174/0118715265275319231124053615.